Summary:
The purpose of the study is to compare effectiveness of paliperidone palmitate versus oral antipsychotic (OAP) on delaying time to treatment failure.
Qualified Participants Must:
• Be between 18 and 35 Years of age
•
Have a current diagnosis of schizophrenia or schizophreniform disorder with a first psychotic episode within the last 24 months
•
Require treatment with an antipsychotic medication
Qualified Participants May Receive:
Study-related medical care and investigational medication at no cost and may be compensated for time and travel.